Efficacy of pentavalent antimony, amphotericin B, and miltefosine in Leishmania amazonensis-infected macrophages under normoxic and hypoxic conditions

Journal of Parasitology

Volumn 94, Issue 6, 2008, Pages 1415-1417

  Ayres, D C ^a   Pinto, L A ^a   Giorgio, S ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIMONY DERIVATIVE; ARTEMISININ; MEGLUMINE ANTIMONATE; MILTEFOSINE; N METHYL GLUCAMINE ANTIMONATE; PENTAVALENT ANTIMONY; UNCLASSIFIED DRUG;

ANTIBIOTICS; ANTIMONY; BIOASSAY; CHEMOTHERAPY; COMPARATIVE STUDY; DRUG; FLAGELLATE; LESION; PARASITE INFESTATION; RODENT;

AMASTIGOTE; ANIMAL CELL; ANTIBIOTIC RESISTANCE; ARTICLE; CELL CULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HYPOXIA; IC 50; IN VITRO STUDY; LEISHMANIA; LEISHMANIASIS; MACROPHAGE; NONHUMAN; OXYGEN TENSION; PARASITE;

AMPHOTERICIN B; ANIMALS; ANTIPROTOZOAL AGENTS; CELL HYPOXIA; DOSE-RESPONSE RELATIONSHIP, DRUG; INHIBITORY CONCENTRATION 50; LEISHMANIA MEXICANA; MACROPHAGES, PERITONEAL; MEGLUMINE; MICE; MICE, INBRED BALB C; ORGANOMETALLIC COMPOUNDS; OXYGEN; PHOSPHORYLCHOLINE;

FUNGI; LEISHMANIA AMAZONENSIS; MURINAE;

EID: 58549119578     PISSN: 00223395     EISSN: None     Source Type: Journal    
DOI: 10.1645/GE-1613.1     Document Type: Article

References (25)

1. ARRAIS-SILVA, W. W., V. A. PAFFARO, JR., A. T. YAMADA, AND S. GIORGIO. 2005. Expression of hypoxia-inducible factor-1alpha in the cutaneous lesions of BALB/c mice infected with Leishmania amazonensis. Experimental Molecular Pathology 78: 49-54.
2. BEGGS, W. H. 1994. Physicochemical cell damage in relation to lethal amphotericin B action. Antimicrobial Agents and Chemotherapy 38: 363-364.
3. BERMAN, J. D. 2003. Current treatment approaches to leishmaniasis. Current Opinion in Infectious Diseases 16: 397-401.
4. BROWN, J. M. 2002. Tumor microenvironment and the response to anticancer therapy. Cancer Biology and Therapy 1: 453-458.
5. BRYANT, R. E., K. FOX, G. OH, AND V. H. MORTHLAND. 1992. Beta-lactam enhancement of aminoglycoside activity under conditions of reduced pH and oxygen tension that may exist in infected tissues. Journal of Infectious Diseases 165: 676-682.
6. CALLAHAN, H. L., A. C. PORTAL, R. DEVEREAUX, AND M. GROGL. 1997. An axenic amastigote system for drug screening. Antimicrobial Agents and Chemotherapy 41: 818-822.
7. CAO, X., L. FANG, S. GIBBS, Y. HUANG, Z. DAI, P. WEN, X. ZHENG, W. SADEE, AND D. SUN. 2007. Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia. Cancer Chemotherapy and Pharmacology 59: 495-505.
8. COLHONE, M. C., W. W. ARRAIS-SILVA, C. PICOLI, AND S. GIORGIO. 2004. Effect of hypoxia on macrophage infection by Leishmania amazonensis. Journal of Parasitology 90: 510-515.
9. DEGROSSOLI, A., M. C. BOSETTO, C. B. LIMA, AND S. GIORGIO. 2007. Expression of hypoxia-inducible factor 1alpha in mononuclear phagocytes infected with Leishmania amazonensis. Immunology Letters 114: 119-125.
10. DESJEUX, P. 2004. Leishmaniasis: Current situation and new perspectives. Comparative Immunology, Microbiology & Infectious Disease 27: 305-318.
11. DIVO, A. A., T. G. GEARY, AND J. B. JENSEN. 1985. Oxygen- and time-dependent effects of antibiotics and selected mitochondrial inhibitors on Plasmodium falciparum in culture. Antimicrobial Agents and Chemotherapy 27: 21-27.
12. EL-ON, J., R. SNEIER, AND E. ELIAS. 1992. Leishmania major: Bacterial contamination of cutaneous lesions in experimental animals. Israel Journal of Medical Sciences 28: 847-851.
13. GRIGORYAN, R., N. KESHELAVA, C. ANDERSON, AND C. P. REYNOLDS. 2005. In vitro testing of chemosensitivity in physiological hypoxia. Methods in Molecular Medicine 110: 87-100.
14. GRIMALDI, G., JR., AND R. B. TESH. 1993. Leishmaniasis of the new world: Current concepts and implications for future research. Clinical Microbiology Reviews 6: 230-250.
15. HYUN, J. Y., Y. S. CHUN, T. Y. KIM, H. L. KIM, M. S. KIM, AND J. W. PARK. 2004. Hypoxia-inducible factor 1alpha-mediated resistance to phenolic anticancer. Chemotherapy 50: 119-126.
16. IKEDA, E. 2005. Cellular response to tissue hypoxia and its involvement in disease progression. Pathology International 55: 603-610.
17. KOCH, S., F. MAYER, M. HONECKER, M. CCHITTENHELM, AND C. BOKEMEYER. 2003. Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro. British Journal of Cancer 89: 2133-2139.
18. KRUNGKRAI, S. R., AND Y. YUTHAVONG. 1987. The antimalarial action on Plasmodium falciparum of qinghaosu and artesunate in combination with agents which modulate oxidant stress. Transactions of the Royal Society of Tropical Medicine and Hygiene 81: 710-714.
19. LUX, H., N. HEISE, T. KLENNER, D. HART, AND F. R. OPPERDOES. 2000. Ether-lipid (alkyl-phospholipid) metabolism and the mechanism of action of ether-lipid analogues in Leishmania. Molecular and Biochemical Parasitology 111: 1-14.
20. MISHRA, J., A. SAXENA, AND S. SINGH. 2007. Chemotherapy of leishmaniasis: Past, present and future. Current Medicinal Chemistry 14: 1153-1169.
21. SANTA-RITA, R. M., A. HENRIQUES-PONS, H. S. BARBOSA, AND S. L. DE CASTRO. 2004. Effect of the lysophospholipid analogues edelfosine, ilmofosine and miltefosine against Leishmania amazonensis. Journal of Antimicrobial Chemotherapy 54: 704-710.
22. SOKOL-ANDERSON, M. L., J. BRAJTBURG, AND G. MEDOFF. 1986. Amphotericin B-induced oxidative damage and killing of Candida albicans. Journal of Infectious Diseases 154: 76-83.
23. SONG, X., X. LIU, W. CHI, Y. LIU, L. WEI, X. WANG, AND J. YU. 2006. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene. Cancer Chemotherapy and Pharmacology 58: 776-784.
24. TEICHER, B. A. 1994. Hypoxia and drug resistance. Cancer Metastasis Reviews 13: 139-168.
25. WYLLIE, S., M. L. CUNNINGHAM, AND A. H. FAIRLAMB. 2004. Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani. Journal of Biological Chemistry 279: 39925-3932.